Biolife Solutions (BLFS) Invested Capital (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Invested Capital data on file, last reported at $374.7 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $374.7 million, up 2.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $374.7 million (up 2.5% YoY), and the FY2025 annual result was $376.9 million, up 3.3% from the prior year.
• Invested Capital fell to $374.7 million in Q1 2026 per BLFS's latest filing, from $376.9 million in the prior quarter.
• Over five years, Invested Capital peaked at $482.9 million in Q1 2022 and troughed at $322.8 million in Q2 2024.
• A 5-year average of $374.8 million and a median of $365.6 million in 2025 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital soared 130.85% in 2022, then retreated 20.68% in 2023.
• A 5-year view of Invested Capital shows it stood at $389.8 million in 2022, then declined by 7.26% to $361.5 million in 2023, then gained by 0.92% to $364.8 million in 2024, then increased by 3.3% to $376.9 million in 2025, then declined by 0.57% to $374.7 million in 2026.
• Business Quant data shows BLFS's Invested Capital at $374.7 million in Q1 2026, $376.9 million in Q4 2025, and $361.2 million in Q3 2025.